|
2024
|
Invention
|
Rbcs-derived extracellular vesicles loaded with cargo molecules for therapeutic applications and ... |
|
|
Invention
|
Plyometric training device. Described is a plyometric training device comprising a frame (2) havi... |
|
2023
|
Invention
|
Variants of the human atm protein for the treatment of diseases related to at least one mutation ... |
|
2021
|
Invention
|
Method for the production of triterpenic acids by in vitro culture of calluses deriving from the ... |
|
2020
|
Invention
|
Isothiocyanate and isoselenocyanate compounds. The present invention relates to a new family of i... |
|
2018
|
Invention
|
Device for emulating energy sources used to power embedded systems/devices. The present invention... |
|
|
Invention
|
Method for the synthesis of glutathione derivatives. 22O with a formation of S,N-diacyl glutathio... |
|
|
Invention
|
Heterocyclic compounds as fluorescent probes for detection in biological systems. 11818; n, r, m ... |
|
|
Invention
|
Machine for chemical analysis comprising the combination of electron ionization mass spectrometry... |
|
2017
|
Invention
|
Pharmaceutical composition of [ (3-hydroxy-4 -pyron-2-yl) methyl] -amine derivatives and dna deme... |
|
2016
|
Invention
|
Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa).
The present... |
|
|
Invention
|
Compositions and methods of inhibiting n-acylethanolamine-hydrolyzing acid amidase. Compounds and... |
|
2015
|
Invention
|
Carbamate derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors. Describe... |
|
|
Invention
|
Amide derivatives of lactam based n-acylethanolamine acid amidase (naaa) inhibitors. Described he... |
|
2014
|
Invention
|
Meta-substituted biphenyl peripherally restricted faah inhibitors. The present invention provides... |
|
2012
|
Invention
|
Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa). The present ... |
|
|
Invention
|
Disubstituted beta-lactones as inhibitors of n-acylethanolamine acid amidase (naaa).
<... |
|
|
Invention
|
Meta-substituted biphenyl peripherally restricted faah inhibitors. The present invention pr... |
|
|
Invention
|
Device and single-molecule analysis method by means of detection of the collisions of a target mo... |
|
2011
|
Invention
|
Modulation of anxiety through blockade of anandamide hydrolysis.
Fatty acid amide hydrolase inhi... |
|
|
Invention
|
Peripherally restricted faah inhibitors. 6 is substituted or unsubstituted cyclohexyl; and the ph... |
|
|
Invention
|
Peripherally restricted faah inhibitors. Peripherally restricted inhibitors of fatty acid amide h... |
|
2009
|
Invention
|
Derivative of [(3-hydroxy-4-pyron-2-yl)-methyl]-amine and use thereof as anti-neoplastic drugs. T... |
|
|
Invention
|
Derivatives of [(3-hydroxy-4 pyron-2-yl)methyl]-amine and use thereof as anti-neoplastic drugs. T... |
|
|
Invention
|
Process for the production of biologically active hiv-1 tat protein. Tat protein produced in bulk... |
|
2008
|
Invention
|
Use of inhibitors of n-acylethanolamine-hydrolyzing acid amidase as anti-inflamatory medicaments.... |
|
2007
|
Invention
|
Delivery of contrasting agents for magnetic resonance imaging. Erythrocytes exposed to dialysis w... |
|
2006
|
Invention
|
Modulation of anxiety through blockade of anandamide hydrolysis. Fatty acid amide hydrolase inhib... |
|
|
Invention
|
Methods, compositions, and compounds for modulation of monoacylglycerol lipase, pain, and stress-... |
|
2004
|
Invention
|
Tetramerous derivative of indole-3-carbinol with anti-carcinogenic activity and method of synthes... |
|
2003
|
Invention
|
Modulation of anxiety through blockade of anandamide hydrolysis.
Fatty acid amide hydr... |
|
2002
|
Invention
|
Germ line mutation in the promoter of e-caderine and diagnostic method for finding a greater susc... |
